http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013106514-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate | 2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013106514-A |
| titleOfInvention | METHODS FOR TREATING GASTROINTESTINAL DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION |
| abstract | 1. A pharmaceutical composition for treating a gastrointestinal disturbance in a patient, wherein the composition comprises: (a) a first solid particle, wherein said first solid particle contains dexlansoprazole and a first enteric coating, wherein the first enteric coating releases dexlansoprazole from the solid at a pH of from about 5.0 to about 5.5; and (b) a second solid particle, wherein said second solid particle contains dexlansoprazole and a second enteric coating, wherein the second enteric coating releases dexlansoprazole from the solid at a pH of from about 6.2 to about 6.8; wherein the first solid particle contains from about 15% to about 50% by weight of the pharmaceutical composition and the second solid particle contains from about 50% to about 85% by weight of the pharmaceutical composition; and further, wherein said pharmaceutical composition can be administered to a patient regardless of a meal. The composition of claim 1, wherein the first enteric coating has a pH of about 5.5.3. The composition of claim 2, wherein the first enteric coating comprises a dispersion of a methacrylic acid copolymer. The composition according to claim 1, in which the second enteric coating has a pH of about 6.75.5. The composition of claim 4, wherein the second enteric coating comprises a mixture of a methacrylic acid type B copolymer and a type A methacrylic acid copolymer in a ratio of 3: 1.6. The composition of claim 1, wherein the first solid particle comprises a protective layer between the active agent and the first enteric coating. The composition according to claim 1, in which |
| priorityDate | 2007-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.